 |
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. Our Keynote Speakers will be Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022). The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022.
Join us on November 2nd & 3rd to hear from leading experts!
 |
 |
We invite attendees to register now
to lock in our $200 rate!
 |
We are offering FREE registration
to students and trainees!
The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022.
The Conference is designed to cover a broad range of domains including:
- Applications of AI & machine learning in psychiatry
- Genomics and other omics
- Precision therapeutics
- Risk stratification for suicide and other important outcomes
- mHealth and digital technologies
- Implementation science
- Ethics and equity
 |
 |
Thomas Insel, MD Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022) Tom lnsel, M.D., a psychiatrist and neuroscientist, has been a national leader in mental health research, policy, and technology. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH). More recently, he led the Mental Health Team at Verily (2015-2017); co-founded Mindstrong Health (2017-2019), a start-up building tools for people with serious mental illness; and served as a special advisor to California Governor Gavin Newsom (2019), helping on behavioral health issues. In 2020, he co-founded Humanest Care, a therapeutic online community for recovery. In 2022, he joined Vanna Health as a co-founder and executive chair. Vanna Health is a start-up helping people with serious mental illness engage in psychosocial supportive care. He currently serves on the boards of Foundation for NIH, Fountain House, Schaeffer Center for Health Policy, and the Steinberg Institute (Chair, 2019-2022) as well as being an advisor to several mental health start-ups (including Alto Neuroscience, Cerebral, Compass Pathways, Owl Insights, Koa Health, Valera Health). He is the author of Healing: Our Path from Mental Illness to Mental Health (Penguin Random House, 2022). With journalist co-founders, he launched MindSite News (www.mindsitenews.org), a non-profit digital publication focused on mental health issues. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe. More info at www.thomasinselmd.com. |
 |
Kelsey Martin, PhD Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA Kelsey Martin, PhD., joined the Simons Foundation in September 2021 as director of SFARI and the Simons Foundation Neuroscience Collaborations. She previously served as dean of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), chair of the UCLA Department of Biological Chemistry and professor in the UCLA Department of Biological Chemistry and the Department of Psychiatry and Biobehavioral Sciences. Her research addresses the cellular and molecular biology of long-term synaptic plasticity and memory, with a focus on experience-dependent regulation of gene expression in neurons. Her lab has discovered signaling molecules that travel from stimulated synapses to the nucleus to impact transcription. They have also elucidated functions for the translation of synaptically localized mRNAs during synapse formation and plasticity. As dean at UCLA, Martin established programs in precision health and computational medicine and developed a series of interdepartmental research initiatives spanning basic through clinical research. Martin earned her bachelor’s degree at Harvard University, her M.D. and Ph.D. in molecular biophysics and biochemistry at Yale University and completed her postdoctoral training with Eric Kandel at Columbia University. She is a member of the National Academy of Medicine and a fellow of the American Academy of Arts and Sciences. Her experience as a Peace Corps volunteer in maternal and child health in Zaire (now the Democratic Republic of Congo) inspired her to pursue a career in medicine and science. |
|
 |
 |
| 1:00pm-1:10pm | Welcome Remarks Jordan W. Smoller, MD, ScD & Maurizio Fava, MD |
|
| 1:10pm-1:40pm | Conference Keynote Thomas Insel, MD Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022) |
|
| 1:40pm-2:00pm | Moderated Discussion/Q&A Thomas Insel, MD Moderator: Jordan W. Smoller, MD, ScD |
|
2:00pm-3:30pm |
Session: Leveraging Healthcare Data for Precision Medicine Session Chair: Colin Walsh |
|
| 2:00pm-2:30pm | Lea Davis, PhD Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center |
|
| 2:30pm-3:00pm | Nigam Shah, PhD Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine |
|
| 3:00pm-3:30pm | Moderated Discussion/Q&A Lea Davis, PhD, Nigam Shah, PhD Moderator: Colin Walsh, MD, MA, FAMIA |
|
| 3:30pm-3:50pm | BREAK | |
3:50pm-4:20pm |
Session: Therapeutics: The Role of Academia and Industry in Advancing Precision Psychiatry Session Chair: Jerrold Rosenbaum, MD |
|
| 3:50pm-4:20pm | Panel Jenny Barnett, PhD Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge; David Olson, PhD Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis; Morgan Sheng, PhD Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard Moderator: Jerrold Rosenbaum, MD |
|
4:20pm-5:20pm |
Session: Precision Treatment Stratification and Pharmacogenetics Session Chair: Roy Perlis, MD, MSc |
|
| 4:20pm-4:50pm | Chad Bousman, PhD CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary |
|
| 4:50pm-5:20pm | Katherine Scangos, MD, PhD Medical Director of Neumora | |
| 5:20pm-5:30pm | Closing Remarks Jordan W. Smoller, MD, ScD |
|
 |
| 9:00am-9:10am | Welcome Remarks Jordan W. Smoller, MD, ScD |
|
| 9:10am-9:40am | Conference Keynote: Kelsey Martin, MD, PhD Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA |
|
| 9:40am-10:00am | Moderated Discussion/Q&A Kelsey Martin, MD, PhD Moderator: Michael Talkowski, PhD |
|
10:00am-11:00am |
Session: Methods and Tools Session Chair: Karmel Choi, PhD |
|
| 10:00am-10:30am | Anthony Philippakis, MD, PhD Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV |
|
| 10:30am-11:00am | Laura Germine, PhD Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project |
|
| 11:00am-12:00pm | Session: Precision Neuroscience & Novel Therapeutics Session Chair: Robert Mealer, MD, PhD |
|
| 11:00am-11:30am | Stephen Haggarty, PhD Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine |
|
| 11:30am-12:00pm | Yasmin Hurd, PhD Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai |
|
| 12:00pm-12:20pm | BREAK | |
12:20pm-12:50pm |
Session: Data & Prediction: The Role of Academia and Industry in Advancing Precision Psychiatry Session Chair: Will Gordon, MD |
|
| 12:20pm-12:50pm | Panel Oliver Harrison, MA, MBBS, MPH Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization; Scott Kollins, PhD Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute Moderator: Will Gordon, MD |
|
12:50pm-1:50pm |
Session: Genomic Medicine Session Chair: Laura Hercher, MA, MS |
|
| 12:50pm-1:20pm | Wendy Chung, MD, PhD Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics |
|
| 1:20pm-1:50pm | Jehannine Austin, PhD, MSc Professor in Dept. of Medical Genetics, University of British Columbia; Executive Director, BC Mental Health and Addictions Research Institute |
|
| 1:50pm-2:20pm | Moderated Discussion Wendy Chung, MD, PhD and Jehannine Austin, PhD, MSc Moderator: Laura Hercher, MA, MS |
|
| 2:20pm-2:30pm | Closing Remarks Jordan W. Smoller, MD, ScD |
|
|
Leading experts will present on a broad range of domains, tools and findings across several major areas of interest in psychiatry, including:
|
|
Jehannine Austin, PhD
Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA
Jennifer Barnett, PhD
Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge
Chad Bousman, PhD
CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary
Wendy Chung, MD, PhD
Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics
Lea Davis, PhD
Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
Laura Germine, PhD
Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project
Stephen Haggarty, PhD
Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine
Oliver Harrison, MA, MBBS, MPH
Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization
Yasmin Hurd, PhD
Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai
Scott Kollins, PhD
Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute
David Olson, PhD
Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis
Anthony Philippakis, MD, PhD
Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV
Nigam Shah, PhD
Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine
Morgan Sheng, PhD
Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Katherine Scangos, MD, PhD
Medical Director, Neumora ; Co-Director TMS and Neuromodulation Program, University of California San Francisco
|
We are excited to offer the opportunity to partner with Massachusetts General Hospital’s Center for Precision Psychiatry to support our second annual Conference on Precision Psychiatry.This two-day conference will feature insight from Massachusetts General Hospital faculty and esteemed experts, showcasing advances in the application of precision medicine.
For more information about sponsoring this program contact the Center for Precision Psychiatry through the form below or send us an email at mghctrprecisionpsych@mgh.harvard.edu
Program Committee Members:
| Megan Candito Karmel Choi, PhD Maurizio Fava, MD Roy Perlis, MD Robbie Mealer, MD, PhD Andy Nierenberg, MD |
Jerrold Rosenbaum, MD Ashley Seiger Jordan Smoller, MD, ScD Sabine Wilhelm, PhD |
